Loading...
Loading...
Testosterone is an important
androgen hormone in the health and well-being of men and women. Testosterone
levels are associated with sexual development, libido, protection against
osteoporosis, and cardiovascular health. In men, insufficient testosterone
levels (hypogonadism) have been linked to obesity and low libido. In women,
polycystic ovary syndrome (PCOS) is a common endocrine disorder that can
result in excessive production of testosterone, leading to infertility,
irregular or absent menstrual periods, and hirsutism (excess body and facial
hair). Inappropriate testosterone levels can also result in precocious or
delayed puberty. The measurement of testosterone plays an important part in
the diagnosis of many conditions and it can guide treatment decisions.
Published studies have shown, however, that many currently available
testosterone tests are not sensitive enough to measure low levels of
testosterone. This limits the clinical utility of these tests. To address this
need and help physicians accurately measure the wide range of testosterone
levels seen in men and women, Abbott announced today clearance from the U.S.
Food and Drug Administration for a new testosterone test.
The new assay runs on Abbott's fully-automated ARCHITECT family of analyzers
and is available in the United States, as well as in several European
countries, Asia Pacific, Latin America, Japan, Africa, the Middle East, and
India, pending country registration.
Intended Use
The ARCHITECT 2^nd Generation Testosterone Assay is a chemiluminescent
microparticle immunoassay for the quantitative determination of testosterone
in human serum and plasma. Measurements of testosterone are used in the
diagnosis and treatment of disorders involving:
o The male sex hormones (androgens) including primary and secondary
hypogonadism, delayed or precocious puberty, and impotence in males; and
o In females, hirsutism (excessive hair) and virilization (masculization)
due to tumors, polycystic ovaries, and androgenital syndromes.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in